Open Consultations

Maize MZIR098 Scientific opinion on application for authorisation of genetically modified Maize MZIR098 for food and feed uses submitted under Regulation (EC) No 1829/2003 by Syngenta (EFSA‐GMO‐DE‐2017‐142) EFSA opinion: 26 June 2020 Deadline: 27 July 2020 Submit comments

EFSA opinion : “The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the eC ry3.1Ab, mC ry3A (Bt´s!, webmaster) and PAT proteins (toxic herbicide glufosinate-ammonium! webmaster) as expressed in maize MZIR 098, and finds no evidence that the genetic modification would change the overall allergenicity of maize MZIR 098. In the context of this application, the consumption of food and feed from maize MZIR 098 does not represent a nutritional concern in humans and animals“.

De wetenschappers van EFSA zien geen enkele giftigheid bij deze gentech mais. Maar de herbiciden en de Bt die er over gesprayd worden dan? Daar doet de EFSA geen onderzoek naar! En dat al jaren! Schande! Dit moet stoppen! Bron/Source.

Fragmenten uit ons bezwaar:

Lees verder “Open Consultations”

Weer een EU markttoelating voor een gentech sojaboon het houdt niet op!

Soybean SYHT0H2

EFSA Scientific Opinion on the Assessment of genetically modified soybean SYHT0H2, for food and feed uses, under Regulation (EC) No 1829/2003

General description of the product
(a) Name of the recipient or parental plant and the intended function of the genetic modification
SYHT0H2 soybean is a genetically modified soybean that is produced by Agrobacterium tumefaciens–mediated transformation. Where cultivated, the intended function of the genetic modification of SYHT0H2 soybean is to facilitate the control of weeds by providing tolerance to HPPD-inhibiting herbicides, such as mesotrione, and to herbicides containing glufosinate ammonium.

From Wikipedia

4-Hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors (HPPD inhbitors) are a class of herbicides that prevent plants by blocking 4-Hydroxyphenylpyruvate dioxygenase, an enzyme in plants that breaks down the amino acid tyrosine into molecules that are then used by plants to create other molecules that plants need.

There is a pharmaceutical drug on the market, nitisinone, that was originally under development as an herbicide as a member of this class, and is used to treat an orphan disease, type I tyrosinemia.


Lees verder “Weer een EU markttoelating voor een gentech sojaboon het houdt niet op!”